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Peptidyl a-amidation activity in bovine adrenal medulla has been localized in chromaffin granules by density gradient 
centrifugation. The activity was found to be both soluble and membrane-associated. Both enzymatic activities were stimu- 
lated by the addition of CuZ+ and ascorbate. The pH maximum for a-amidation in the chromaffin granules in pH 8&8.5. 
By gel filtration, the soluble enzyme activity appeared as a protein of approx. 40 kDa. It is suggested that this enzyme 
is involved in the carboxyl-terminal midation of metorphamide, amidorphin and neuropeptide Y. 
Chromaffin granule; Peptidyl glycine a-amidating monooxygenase 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Carboxyl-terminal cu-amidation is a frequent 
feature of bioactive peptides. This essential post- 
translational modification is catalysed by an en- 
zyme known as peptidyl a-amidating monoox- 
ygenase (PAM). It was originally identified in the 
soluble fraction of pituitary secretory granules [ 11, 
has been shown to be stimulated by copper and 
ascorbate and to be dependent on the presence of 
molecular oxygen [2]. 
Since several neuropeptides have been found in 
chromaffin granules of adrenal medulla [3], in- 
cluding the amidated peptides neuropeptide Y [4], 
metorphamide [5] and amidorphin [6], we in- 
vestigated whether an cu-amidation activity is pre- 
sent in the adrenal medulla. 
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2.1. Preparation of soluble and membrane proteins from 
chrotnaffin granules 
Chromaffin granules were isolated over 1.8 M sucrose ac- 
cording to [7]. The granules were lysed in 20 mM Na-Tes 
(pH 8.0) at 4°C for 1 h. After freeze-thawing, the membranes 
were sedimented at 100000 x g,, for 30 min and the superna- 
tant was used as a source for soluble proteins. Membranes were 
further purified by three washes with lysis buffer and cycles of 
freeze-thawing. 
2.2. Subcellular fractionation of bovine adrenal medulla 
A crude granule fraction was obtained essentially as in IS]. 
This fraction was resuspended in 0.3 M sucrose and layered on- 
to a linear sucrose gradient of 1.1-2.2 M sucrose. This gradient 
was centrifuged for 2 h at 272000 x g,., and 12 fractions were 
collected afterwards. 
2.3. PAM assay 
A PAM enzyme assay was adapted from [2] which tests en- 
zyme sources according to their ability to convert “‘1-D-Tyr- 
Val-Gly into “‘I-D-Tyr-Val-NHz. Assays were generally per- 
formed in a volume of 100~1 for 5 h with 10-40/g protein, 
0.5 /tM D-Tyr-Val-Gly, 15000-30000 cpm ‘251-D-Tyr-Val-Gly, 
100 mM Na-Tes (PH 8.0), catalase (100 pg/ml) and various 
amounts of CuSO., and/or ascorbate. After incubation, 
substrate and product were separated by cation-exchange 
chromatography. Data are expressed as pmol D-Tyr-Val-NH2 
formed/mg protein per h. 
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2.2. Other assays Table 1 
Catecholamines were assayed by the method of Von Euler 
and Hamberg [9]. Protein was estimated by the method of 
Bradford [lo]. Acid phosphatase and succinate hydrogenase 
were assayed as in [11,12], respectively. Dopamine-fl- 
monooxygenase (DBM) was assayed as in [13]. 
Comparison between the membraneous and soluble (Y- 
amidation activities from chromaffin granules 
2.5. Gel-filtration chromatography 
The soluble proteins of chromaffin granules were concen- 
trated by precipitation with 50% saturated ammonium sulfate 
and applied to a Superose-12 HR lo/30 column (Pharmacia). 
The column was equilibrated with 20 mM Na-Tes (pH 8.0) and 
I-min fractions were collected at a flow rate of 0.5 ml/min. 
pH optimum 
CuSO4 stimulation (-fold) 
CuSO4 optimum (uM) 
Ascorbate stimulation (-fold) 
Ascorbate optimum (mM) 
3. RESULTS 
3.1. Peptidyl cu-amidation activity in chromaffin 
granules 
Low, but detectable amidation activity was 
found in the homogenate of bovine adrenal 
medulla. In the soluble fraction of chromaffin 
granules, however, significantly higher activity was 
present. 
Reversed-phase HPLC analysis of the reaction 
products formed by the granule-associated activity 
indicated that more than 95% of the labeled reac- 
tion product co-eluted with synthetic 12’I-D- 
Tyr-Val-NHz. 
The pH optimum for the granule-associated a-
amidation activity was found to be pH 8.0, with a 
rapid decline in activity below pH 6.5 (fig.1). The 
reaction was linear both in amount of granule pro- 
tein, up to 50 pug protein/assay tube, and with time 
to about 6 h. A boiled enzyme blank showed no 
activity. Of all metal ions tested, only copper was 
capable of stimulating the amidation activity and 
of reversing the inhibitory effect of EDTA. Max- 
-e oJ 
0 
1 - I - I - , 1 1 
5 6 7 6 ’ PH 
Fig. 1. pH dependence of soluble and membraneous chromaffin 
granule PAM activity. All assays contained 5 PM CuSO4 and 
0.5 mM ascorbate at the pH indicated. Maximal activity was 
25 pmol/mg protein per h. 
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imal stimulation of PAM activity was obtained at 
l-5 PM, and varied slightly with each preparation 
of granules. This copper concentration resulted in 
5-6-fold stimulation of amidation activity (table 
1). Addition of optimal levels of ascorbate 
(0.5 mM) stimulated PAM activity 1.5-2-fold 
(table 1). Higher levels of ascorbate had an in- 
hibitory effect on the activity. When the soluble 
fraction of chromaffin granules was chromato- 
graphed on a Superose-12 gel-filtration column, 
the major activity emerged at an elution position 
corresponding to approx. 40 kDa (fig.2). 
There was also a significant amount of PAM ac- 
tivity in the membranes of chromaffin granules. 
This activity was solubilised by non-ionic 
detergents uch as Triton X-100, but not by high 
salt concentrations. Membraneous PAM activity 
was also stimulated by copper and ascorbate (table 
l), and showed a pH optimum at pH 8.0 (fig.1). 
3.2. Sucrose density gradient centrifugation 
Even highly purified granules are not completely 
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Fig.2. Gel filtration on a Superose-12 column of a soluble 
fraction from chromaffin granules. PAM activity was 
determined in the presence of 5 FM CuSO4 and 0.5 mM 
ascorbate. Numbers above profile in kDa. 
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Fig.3. Sucrose density gradient fractionation of a large granule fraction. Each fraction was measured for catecholamines and density; 
succinate dehydrogenase and acid phosphatase, and DBM and PAM. 
free from contamination with other cell particles. 
Therefore, we compared the distribution of PAM 
with that of markers for various cell particles in 
fractions obtained by density gradient centrifuga- 
tion. In this gradient (fig.3) the distribution of 
PAM closely matched that of catecholamines and 
DBM, i.e. markers for chromaffin granules. 
4. DISCUSSION 
Since the soluble cx-amidating enzyme 
characterized in the chromaffin granule is 
stimulated by Cu*+ and ascorbate, it probably 
belongs to the same family as other PAM enzymes 
[14,15]. 
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The relatively broad peak of activity with a max- 
imum of 40 kDa observed on gel filtration may 
reflect different forms of PAM in chromaffin 
granules. Previous reports have indeed reported 
heterogeneity in the apparent molecular mass of 
the enzyme in the pituitary, which was separated 
into two components of 54 and 38 kDa [16]. 
The subcellular fractionation experiments prove 
the presence of PAM in chromaffin granules. In 
accordance with two recent reports of PAM in the 
heart [ 171 and pituitary [ 181, membrane-associated 
PAM activity was also found in chromaffin 
granules. The membraneous and soluble forms of 
chromaffin granule PAM have nearly identical 
characteristics with respect to pH optimum and 
copper and ascorbate requirements. It is not yet 
clear whether the membrane form of PAM is 
similar to the putative precursor of PAM, for the 
sequence of this precursor [19] contains a 
membrane-spanning domain. 
The finding that PAM is present in chromaffin 
granules is intriguing. There is a striking similarity 
of the enzyme to DBM [2], an important compo- 
nent of chromaffin granules. The relationship be- 
tween these two enzymatic reactions occurring in 
the same granule seems an interesting topic for fur- 
ther research. 
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